新城發展(01030.HK)3月實現合約銷售金額約21.27億元
格隆匯4月10日丨新城發展(01030.HK)公吿,於2025年3月,集團實現合約銷售金額約人民幣21.27億元,合約銷售面積約27.15萬平方米。
2025年1月至3月累計合同銷售金額約人民幣51.02億元,累計銷售面積約65.77萬平方米。
於2025年3月,集團房地產出租物業共174個,總建築面積約1,604.40萬平方米;2025年3月份租金收入約人民幣10.81億元,商業運營收入約人民幣11.59億元(即含税租金收入)。
2025年1月至3月累計租金收入約人民幣32.16億元,累計商業運營收入約人民幣34.48億元(即含税租金收入)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.